BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ·Healthcare·Biotechnology
$60.65
+1.09%
Mkt Cap $11.60B
Analyst Ratings
Buy
16
Hold
4
Sell
0
Price Target (66 analysts)
$89.21
Range $50.00 – $120.00
Implied Upside
+47.1%
Consensus $89.21 vs current $60.65
NASDAQ·Healthcare·Biotechnology
$60.65
+1.09%
Mkt Cap $11.60B
Buy
16
Hold
4
Sell
0
Price Target (66 analysts)
$89.21
Range $50.00 – $120.00
+47.1%
Consensus $89.21 vs current $60.65